Skip to main content
. 2018 Jul 24;24:5139–5146. doi: 10.12659/MSM.908840

Figure 1.

Figure 1

Biomarker values according to left ventricular ejection fraction. Comparison of galectin-3 (A), sST2 (B), and NT-proBNP (C) between HFpEF, HFrEF, and controls. Soluble suppression of tumorigenicity-2 (sST2), N-terminal pro-B-type natriuretic peptide (NT-proBNP). * P<0.05 vs. Control, # P<0.05 vs. HFpEF.